Investor Releases

Date	Title	View
16 June, 2009	ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester
09 June, 2009	ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
28 April, 2009	ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility
28 April, 2009	ICON Acquires Assets of Qualia Clinical Services, Inc.
24 April, 2009	ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors
07 April, 2009	ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India
16 March, 2009	ICON and MedAvante Sign Alliance Agreement
23 February, 2009	ICON reports Full-Year 2008 revenue growth of 37% operating income growth of 44% and EPS growth of 38% (NASDAQ:ICLR) (ISIN:IE0005711209)
26 January, 2009	ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
19 January, 2009	ICON Recognised as Research Company of the Year at the PharmaTimes Awards
09 January, 2009	ICON Issues Financial Guidance for 2009 and Updates Guidance for 2008(NASDAQ:ICLR) (ISIN:IE0005711209)
08 January, 2009	ICON plc Acquires Remaining 30% Stake in Beacon Bioscience Inc.
15 December, 2008	ICON Announces Guidance date for 2009
10 December, 2008	ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software
18 November, 2008	Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US
14 November, 2008	ICON Acquires Prevalere Life Sciences Inc
12 November, 2008	ICON Opens Full Service Central Laboratory in India
21 October, 2008	ICON reports 35% increase in revenue and 45% increase in operating income
09 September, 2008	ICON Central Laboratories Appoints Chief Operating Officer
14 August, 2008	ICON announces completion of “Stock Split”

Investor Releases

Investor Releases

Search Investor